Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 19. Juli 2025
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8446  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 168907  
   
Long-term outcome of transurethral laser ablation for recurrent non-muscle invasive bladder cancer: An EORTC risk-matched study.
BJUI Compass
Ng CPY, Light A, Eleftheriou C, Hug O, Richardson E, Gill-Taylor T, Shamsuddin A, Abboudi H, Agrawal S.
PMID: 40678112 [PubMed]


The impact of METTL3 on bladder cancer through m(6)A modification: a potential therapeutic target and prognostic biomarker.
Front Oncol
Wen D, Fu P, Shuai G, Wang Y, Yu S, Liu H, Wan W, Zou J, Zou X.
PMID: 40678060 [PubMed]


Development and validation of nomograms for predicting prognosis in patients with resectable bladder urothelial carcinoma undergoing radical cystectomy: a multicenter retrospective study.
Front Oncol
Ji J, Wen Z, Yao Y, Jiang L, Yang Q, Zhang G.
PMID: 40678059 [PubMed]


Health impact of using anti-PD-(L)1 agents to treat early-stage cancers in Switzerland: a modeling study.
Front Immunol
Favre-Bulle A, Stankovi, Mantaian T, Frei C, Schaefer S, Gabriel SS, Sönmez D, Aguiar-Ibáñez R.
PMID: 40677709 [PubMed - indexed for MEDLINE]


Advances in immunotherapy and targeted therapy for advanced clear-cell renal cell carcinoma: current strategies and future directions.
Front Immunol
Wang B, Xiang Y, Liu X, Pan X, Peng L, Ma J.
PMID: 40677703 [PubMed - indexed for MEDLINE]


Moving from a registry to a learning health system: A case study of a Dutch prostate cancer registry.
Learn Health Syst
Belleman T, van Wijngaarden JDH, Kuppen MCP, de Groot S, van der Velden KJM, Bosch D, van Oort IM, Uyl-de Groot CA, van Deen WK.
PMID: 40677594 [PubMed]


Association of Perirectal Hydrogel Spacer Placement with Clinical Outcomes in Patients with Prostate Cancer Undergoing Radiotherapy: A Systematic Review and Meta-Analysis.
World J Mens Health
Kwon JK, Jeon J, Bang S, Koo KC, Cho KS, Kim DK.
PMID: 40676889 [PubMed - as supplied by publisher]


Prognostic and Predictive Value of Machine Learning-Based Biomarker and Pathomics Signatures in Patients With Prostate Cancer.
Cancer Sci
Zhang J, Pan J, Lin J, Cai Y, Liu Y, Lin F, Guan H, Zhou G, Wei D, Wang Z, Ma Y, Zhao Z.
PMID: 40676748 [PubMed - as supplied by publisher]


Onco-nephrology in clinical practice: pharmacokinetics, monitoring, and treatment strategies for patients with cancer and impaired renal function.
Int J Clin Oncol
Nakagawa S, Ikuta K, Masuda T, Terada T.
PMID: 40676437 [PubMed - as supplied by publisher]


PSA proportion of index lesion: a novel index for predicting prostate pathology outcomes in biopsy-naïve patients with PSA < 10 ng/ml and PI-RADS 3 lesions.
World J Urol
Mo H, Hu C, Li P, Miao Z, Zhang H, Shen G, Sun J.
PMID: 40676360 [PubMed - indexed for MEDLINE]


Novel risk predictor of spontaneous rupture and hemorrhage of renal cell carcinoma based on clinical and radiographic characteristics.
World J Urol
Lin B, Li XD, Liu MX, Xue YT, Huang XY, Ke ZB, Chen JY, Lin F, Zheng QS, Wei Y, Xue XY, Chen SH, Xu N.
PMID: 40676338 [PubMed - indexed for MEDLINE]


PSA density correlates to pathology T stage and ISUP grade: insights from a cohort of 3568 radical prostatectomy cases.
World J Urol
Pattou M, Neuzillet Y, Ghoneim T, Bosset PO, Herve JM, Vanalderwerelt V, Bohin D, Lugagne PM, Soorojebally Y, Lebret T.
PMID: 40676316 [PubMed - indexed for MEDLINE]


Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial.
Eur Urol Oncol
Phillips RM, Proudfoot JA, Davicioni E, Liu Y, Spratt DE, Simko JM, Den RB, Pollack A, Rosenthal SA, Sartor AO, Sweeney CJ, Attard G, Longoria L, Patel S, Straza MW, Efstathiou JA, Shah AB, Hoffman KE, Rodgers JP, Sandler HM, Feng FY, Tran PT.
PMID: 40675873 [PubMed - as supplied by publisher]


Interspecies Variability in Biodistribution and PET Imaging Performance of [(18)F]Di-PyL: A Dimeric, PSMA-Targeted PET Agent for Prostate Cancer.
J Nucl Med
Chen Y, Zhang X, Wang X, Liu Y, Zhang J, Cui M.
PMID: 40675754 [PubMed - as supplied by publisher]


Use of hybrid quantum-classical algorithms for enhancing biomarker classification.
PLoS One
Astuti A, Shih PK, Lee SC, Mekala VR, Wijaya EB, Ng KL.
PMID: 40674380 [PubMed - indexed for MEDLINE]


SOX2, PIWI proteins, and MALAT1 - plasma-based emerging biomarkers for cancer detection and monitoring.
PLoS One
Kldiashvili E, Abiatari I, Kekelia E, Iordanishvili S, Metreveli T, Dumbadze E.
PMID: 40674376 [PubMed - indexed for MEDLINE]


FDA Approval Summary: Niraparib Plus Abiraterone Acetate Fixed Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
Maguire WF, Chi DC, Agrawal S, Joeng HK, Kim-McOlash S, Manheng W, Bulatao I, Sanchez-Solana B, Pathak A, Lee A, Han Y, Ricks TK, Hamed SS, Fiero MH, Pierce WF, Kalavar S, Ghosh S, Leighton JK, Tang S, Amiri-Kordestani L, Kluetz PG, Suzman DL.
PMID: 40673886 [PubMed - as supplied by publisher]


Identification and Validation of a Prognostic Model Based on Tumour Necrosis Factor-Related mRNAs for Kidney Renal Clear Cell Carcinoma.
J Cell Mol Med
Hu Z, Zhou Y, Xie L, Zhang S, Liu Y, Zhang W, Huang T.
PMID: 40673609 [PubMed - indexed for MEDLINE]


Risk factors for low-risk prostate cancer: A retrospective cohort study within the FinRSPC trial.
Int J Cancer
Okwor UE, Raitanen J, Talala K, Tammela TLJ, Taari K, Kujala P, Auvinen A.
PMID: 40673336 [PubMed - as supplied by publisher]


Pancreatic Fistula after Laparoscopic Radical Nephrectomy.
Prague Med Rep
Caliskan S.
PMID: 40673329 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 168907    Seite 1 von 8446  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1